Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management – Business Wire (press release)
|
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million in Assets Under Management
Business Wire (press release) Launched with a modest seed investment of $2.5 million on Oct. 13, 2015, the ETF has been offering exposure to public companies at the forefront of cancer immunotherapy research for more than two years. Cancer immunotherapy has become an important … |
